Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2000Arteriosclerosis Thrombosis and Vascular BiologyOpen Access

Apolipoprotein Concentrations During Treatment and Recurrent Coronary Artery Disease Events

View Full Paper
Ask AI
Bookmark
Share

Authors

JLJeanine E. Roeters van LennepPreventive CardiologyHWH. Tineke WesterveldUtrecht UniversityHLHenk W. O. Roeters van LennepUtrecht University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lennep et al. (2000) studied this question.

synapsesocial.com/papers/6a780601f6b553d308aeee62https://doi.org/10.1161/01.atv.20.11.2408
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels1998 · 5,308 citations
  2. 2Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia1995 · 7,496 citations
  3. 3Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels1998 · 5,296 citations
  4. 4The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels1996 · 7,500 citations
  5. 5New Perspectives on the Management of Low Levels of High-Density Lipoprotein Cholesterol1999 · 70 citations